Sleep Aids - ASEAN

ASEAN

Highlights

Revenue in the Sleep Aids market amounts to US$145.10m in 2024. The market is expected to grow annually by 8.44% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$2bn in 2024).
In relation to total population figures, per person revenues of US$0.21 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Sleep Aids market in ASEAN is experiencing significant growth and development, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in ASEAN are increasingly prioritizing their sleep health and are seeking solutions to improve their quality of sleep. This shift in customer preferences can be attributed to various factors such as increasing awareness about the importance of sleep, rising stress levels, and the growing prevalence of sleep disorders. As a result, there is a growing demand for sleep aids in the region.

Trends in the market: One of the key trends in the Sleep Aids market in ASEAN is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of conventional sleep aids and are seeking safer alternatives. This has led to an increase in the demand for natural sleep aids that are made from herbal ingredients. Manufacturers are responding to this trend by introducing a wide range of natural sleep aids in the market. Another trend in the market is the growing adoption of technology-driven sleep aids. With the advancement of technology, customers now have access to a variety of sleep tracking devices and smartphone applications that help monitor and improve their sleep patterns. These devices and apps provide valuable insights into sleep quality and offer personalized recommendations to enhance sleep. As a result, the market for technology-driven sleep aids is witnessing significant growth in ASEAN.

Local special circumstances: ASEAN countries have diverse cultural and lifestyle factors that influence the Sleep Aids market. For example, countries like Thailand and Indonesia have a strong tradition of using herbal remedies for various health issues, including sleep problems. This cultural inclination towards natural remedies has contributed to the popularity of herbal sleep aids in these countries. Moreover, the high levels of urbanization and the fast-paced lifestyle in ASEAN countries have led to increased stress levels and disrupted sleep patterns. This has created a need for sleep aids to help individuals cope with sleep disorders and improve their overall sleep quality.

Underlying macroeconomic factors: The growing middle-class population in ASEAN countries, coupled with rising disposable incomes, has played a significant role in driving the growth of the Sleep Aids market. As people become more affluent, they are willing to spend on products and services that improve their quality of life, including sleep aids. Furthermore, the increasing prevalence of sleep disorders in ASEAN countries has also contributed to the growth of the Sleep Aids market. Factors such as changing lifestyles, work-related stress, and the aging population have resulted in a higher incidence of sleep disorders, creating a larger customer base for sleep aids. In conclusion, the Sleep Aids market in ASEAN is witnessing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for natural and herbal sleep aids, the adoption of technology-driven sleep aids, cultural inclinations towards herbal remedies, and the rising prevalence of sleep disorders are all contributing to the growth of the market in this region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.